On this episode of The Pharmaverse Podcast, Art Krieg, the President of Zola Therapeutics, tells Michael that vision, endurance, resilience, and a whole lot of grit are needed to run a biotech.

Krieg has faced the rugged terrain and uphill climbs that come with building science-based companies. But just like a marathoner, he’s never stopped putting one foot in front of the other.

🎧 In this episode, Art and Michael discuss:
 ✅ The parallels between biotech leadership and long-distance running
 ✅ Lessons learned from exits, IPOs, and immuno-oncology breakthroughs
 ✅ Why perseverance and pacing are more important than ever in today’s market

📲 Follow The Pharmaverse Podcast on LinkedIn, X, YouTube, or wherever you get your podcasts.
#pharmaversepodcast 

  𝐂𝐎𝐍𝐍𝐄𝐂𝐓 𝐖𝐈𝐓𝐇 𝐔𝐒:
▶  Website: [https://www.kbic.com/recruiting/pharm...]
▶  LinkedIn: [ https://www.linkedin.com/in/michaelpietrack/   ]
▶ Website: [ https://linktr.ee/pharmaverse ] 
▶ Check out his podcast:[ https://www.linkedin.com/company/99101554 ]
▶ Have you seen all of our playlists?                  [https://www.youtube.com/@ThePharmaversePodcast/playlists ]
▶ Also, join the private LinkedIn Job Board: MSL Job Board